Among patients with genetically confirmed myxoid liposarcoma, 22% developed metastatic disease, with the first metastatic site being intra-abdominal in 5 of 7 cases, highlighting a strong tendency for extrapulmonary spread.
Cohort (n=32)
No
Myxoid liposarcomas frequently metastasize to extrapulmonary sites, particularly soft tissues and the abdomen, suggesting that whole-body imaging may be indicated for staging and follow-up.
BACKGROUND: Most sarcomas metastasize predominantly to the lungs, and chest x-ray, or computed tomography, is the most commonly used staging investigation. Myxoid liposarcomas (MLSs) are rare tumors with a tendency to metastasize to extrapulmonary loci. The aim of this study was to assess the locations of the first metastases in MLS patients, to guide the design of effective staging and follow-up imaging protocols. METHODS: Patients treated for MLS between 1987 and 2017 were identified in a prospectively maintained register. Histology of the tumors was reassessed. In addition, the presence of one of the pathognomonic gene translocations was confirmed, uniquely for a retrospective series. The surgical and oncological outcomes were reviewed. A comprehensive review of the literature was performed on the metastatic pattern of MLS, including series with 10 or more MLS patients with metastatic disease. RESULTS: A total of 32 patients with genetically confirmed MLS were identified, with a median follow-up of 7.6 years. Seven patients (22%) developed metastatic disease, five initially intra-abdominally and only one to the lungs. The comprehensive review included 14 series with 1853 patients, 348 (19%) of whom had metastases. The location of the first metastases was soft tissues in 32% of patients, intra-abdominal in 26%, pulmonary in 24%, and bone in 17%. CONCLUSIONS: MLSs metastasize often intra-abdominally and to extra-abdominal soft tissues. Thus, whole-body imaging may be indicated during the initial assessment and follow-up of these patients.
Homsy et al. (Sun,) conducted a cohort in Myxoid Liposarcoma (n=32). Myxoid liposarcoma was evaluated on Development and location of first metastases. Among patients with genetically confirmed myxoid liposarcoma, 22% developed metastatic disease, with the first metastatic site being intra-abdominal in 5 of 7 cases, highlighting a strong tendency for extrapulmonary spread.